Ultragenyx Pharmaceutical Inc. (RARE) by event type
RARE moves most on analyst downgrades — a median of +2.60% at 30 minutes across 28 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the RARE overview →
How RARE reacts across 5 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst downgrades 16 of 2,603 | 28 | +2.60% | 79% | +3.17% |
| Coverage initiations 2,084 of 2,283 | 13 | -0.90% | 39% | -3.21% |
| Rating reiterations 451 of 3,522 | 143 | +0.20% | 59% | +0.27% |
| Price-target raises 802 of 1,790 | 38 | +0.02% | 53% | +0.06% |
| Price-target cuts 27 of 1,527 | 41 | +0.61% | 66% | +0.61% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 1 further class was observed with fewer than 10 measured events and is not published.
That’s how RARE usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst downgrades → · Coverage initiations → · Rating reiterations → · Price-target raises → · Price-target cuts → · RARE overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Quotient Limited - Ordinary Shares (QTNT) | 982 | -0.13% | 42% |
| PDL BIOPHARMA (PDLI) | 967 | 0.00% | 46% |
| QuidelOrtho Corporation (QDEL) | 965 | +0.02% | 50% |
| Recro Pharma, Inc. (REPH) | 965 | 0.00% | 43% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.